Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases
Por um escritor misterioso
Last updated 01 abril 2025

Niemann-Pick disease type C (NP-C) is a rare, autosomal recessive, neurodegenerative disease associated with a wide variety of progressive neurological manifestations. Miglustat is indicated for the treatment of progressive neurological manifestations in both adults and children. Since approval in 2009 there has been a vast growth in clinical experience with miglustat. The effectiveness of miglustat has been assessed using a range of measures. Comprehensive review of published data from studies of cellular neuropathological markers and structural neurological indices in the brain, clinical impairment/disability, specific clinical neurological manifestations, and patient survival. Cranial diffusion tensor imaging and magnetic resonance spectroscopy studies have shown reduced levels of choline (a neurodegeneration marker), and choline/N-acetyl aspartate ratio (indicating increased neuronal viability) in the brain during up to 5 years of miglustat therapy, as well as a slowing of reductions in fractional anisotropy (an axonal/myelin integrity marker). A 2-year immunoassay study showed significant reductions in CSF-calbindin during treatment, indicating reduced cerebellar Purkinje cell loss. Magnetic resonance imaging studies have demonstrated a protective effect of miglustat on cerebellar and subcortical structure that correlated with clinical symptom severity. Numerous cohort studies assessing core neurological manifestations (impaired ambulation, manipulation, speech, swallowing, other) using NP-C disability scales indicate neurological stabilization over 2–8 years, with a trend for greater benefits in patients with older (non-infantile) age at neurological onset. A randomized controlled trial and several cohort studies have reported improvements or stabilization of saccadic eye movements during 1–5 years of therapy. Swallowing was also shown to improve/remain stable during the randomized trial (up to 2 years), as well as in long-term observational cohorts (up to 6 years). A meta-analysis of dysphagia – a potent risk factor for aspiration pneumonia and premature death in NP-C – demonstrated a survival benefit with miglustat due to improved/stabilized swallowing function. The effects of miglustat on neurological NP-C manifestations has been assessed using a range of approaches, with benefits ranging from cellular changes in the brain through to visible clinical improvements and improved survival.

Clinical disease characteristics of patients with Niemann-Pick

Patient with Niemann-Pick disease type C: over 20 years' follow-up

Recommendations for the diagnosis and management of Niemann-Pick

Finding pathogenic commonalities between Niemann-Pick type C and

PDF) Review Niemann-Pick disease type C

IJMS, Free Full-Text

Effects of Miglustat on Stabilization of Neurological Disorder in

Dysphagia as a risk factor for mortality in Niemann-Pick disease

Imaging of neuroinflammation in adult Niemann-Pick type C disease
Recomendado para você
-
Niemann–Pick disease - Wikipedia01 abril 2025
-
Doença de Niemann-Pick C (NPC) by Ekthor Henrique01 abril 2025
-
Doença Rara Niemann-Pick tipo C – SNS01 abril 2025
-
Consulta pública avalia tratamento no SUS para pacientes com01 abril 2025
-
Mãe se torna enfermeira para cuidar do filho com doença rara: 'Ele01 abril 2025
-
Niemann-Pick Disease - Western New York Urology Associates01 abril 2025
-
Associação Niemann-Pick Brasil01 abril 2025
-
Radiografía de tórax en un paciente con enfermedad de Niemann Pick01 abril 2025
-
Proposed diagnostic algorithm for patients with suspected Niemann01 abril 2025
-
Niemann-Pick tipo C: entenda uma das doenças que causa demência01 abril 2025
você pode gostar
-
6 New Spider-Characters In 'Spider-Man: Across The Spider-Verse01 abril 2025
-
Play Bubble Smash Online for Free on PC & Mobile01 abril 2025
-
Most Memorable Elden Ring Quotes01 abril 2025
-
Xbox Game Pass vs. PlayStation Now: Which Is the Better Deal?01 abril 2025
-
Sans Au Art - Ireland01 abril 2025
-
Editora CRV01 abril 2025
-
Cyberpunk 2077 Gets a Third-Person PC Mod - IGN01 abril 2025
-
Relógio Digital Smartwatch Inteligente Laranja Amax Ultra ISO Android - Resistente a àgua - Smartwatch e Acessórios - Magazine Luiza01 abril 2025
-
Sea of Stars Release Date Delayed to 2023, Demo Planned for 202201 abril 2025
-
FIFA 21: James Rodriguez Moments disponível em DME, Planeta FUT01 abril 2025